Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes
Public ClinicalTrials.gov record NCT00141492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double Blind, Randomized, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of Androgel, as an Adjunct to Hypoglycemic Therapy, in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is to investigate how well Androgel, when tested against placebo gel, helps to control blood sugar levels in males with type 2 diabetes who have low testosterone (the main male hormone) blood levels and are taking oral diabetic medicines alone or in combination with insulin.
Study identification
- NCT ID
- NCT00141492
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years to 80 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2004 (Type not available)
- Primary completion
- Jun 2007 (Actual)
- Completion
- Jun 2007 (Actual)
- Last update posted
- Jan 21, 2015
2004 – 2007
United States locations
- U.S. sites
- 70
- U.S. states
- 27
- U.S. cities
- 57
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 58 | Birmingham | Alabama | — | — |
| Site 67 | Calera | Alabama | — | — |
| Site 54 | Mobile | Alabama | — | — |
| Site 16 | Phoenix | Arizona | — | — |
| Site 35 | Anaheim | California | — | — |
| Site 23 | Concord | California | — | — |
| Site 55 | La Jolla | California | — | — |
| Site 8 | Los Gatos | California | — | — |
| Site 12 | Mission Viejo | California | — | — |
| Site 1 | Torrance | California | — | — |
| Site 25 | Glastonbury | Connecticut | — | — |
| Site 13 | Fort Lauderdale | Florida | — | — |
| Site 43 | Jacksonville | Florida | — | — |
| Site 33 | Ocala | Florida | — | — |
| Site 27 | Tampa | Florida | — | — |
| Site 21 | West Palm Beach | Florida | — | — |
| Site 7 | Atlanta | Georgia | — | — |
| Site 26 | Columbus | Georgia | — | — |
| Site 29 | Boise | Idaho | — | — |
| Site 45 | Idaho Falls | Idaho | — | — |
| Site 51 | Chicago | Illinois | — | — |
| Site 32 | Des Moines | Iowa | — | — |
| Site 5 | Baton Rouge | Louisiana | — | — |
| Site 70 | Baltimore | Maryland | — | — |
| Site 9 | Springfield | Massachusetts | — | — |
| Site 48 | Watertown | Massachusetts | — | — |
| Site 19 | Detroit | Michigan | — | — |
| Site 61 | Livonia | Michigan | — | — |
| Site 40 | Tupelo | Mississippi | — | — |
| Site 65 | Chesterfield | Missouri | — | — |
| Site 15 | Kansas City | Missouri | — | — |
| Site 41 | Omaha | Nebraska | — | — |
| Site 34 | Las Vegas | Nevada | — | — |
| Site 24 | Jersey City | New Jersey | — | — |
| Site 49 | Buffalo | New York | — | — |
| Site 71 | New York | New York | — | — |
| Site 44 | Fayetteville | North Carolina | — | — |
| Site 28 | Morehead City | North Carolina | — | — |
| Site 60 | Morehead City | North Carolina | — | — |
| Site 31 | Portland | Oregon | — | — |
| Site 3 | Portland | Oregon | — | — |
| Site 68 | Altoona | Pennsylvania | — | — |
| Site 4 | Bala-Cynwyd | Pennsylvania | — | — |
| Site 64 | Carlisle | Pennsylvania | — | — |
| Site 38 | Lansdale | Pennsylvania | — | — |
| Site 46 | Shippensburg | Pennsylvania | — | — |
| Site 14 | Greer | South Carolina | — | — |
| Site 20 | Arlington | Texas | — | — |
| Site 11 | Dallas | Texas | — | — |
| Site 10 | Houston | Texas | — | — |
| Site 18 | Houston | Texas | — | — |
| Site 2 | Houston | Texas | — | — |
| Site 36 | Houston | Texas | — | — |
| Site 39 | Houston | Texas | — | — |
| Site 42 | Houston | Texas | — | — |
| Site 47 | Houston | Texas | — | — |
| Site 53 | Houston | Texas | — | — |
| Site 62 | Houston | Texas | — | — |
| Site 63 | Houston | Texas | — | — |
| Site 69 | Houston | Texas | — | — |
| Site 6 | Humble | Texas | — | — |
| Site 30 | La Porte | Texas | — | — |
| Site 66 | Midland | Texas | — | — |
| Site 37 | San Antonio | Texas | — | — |
| Site 56 | Sugarland | Texas | — | — |
| Site 57 | Sugarland | Texas | — | — |
| Site 52 | Ogden | Utah | — | — |
| Site 17 | Salt Lake City | Utah | — | — |
| Site 22 | Salem | Virginia | — | — |
| Site 50 | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00141492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2015 · Synced Sep 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00141492 live on ClinicalTrials.gov.